The April 2026 edition of the ImageProVision Newsletter highlights significant advancements in pharmaceutical analytical technology, organizational growth, and employee engagement.
This month, we showcased CLAIRITY™ AUTO, our automated particulate matter analysis solution designed for compliance with USP <788> and USP <789>. The system delivers automated detection, quantification, and classification of visible and subvisible particulate matter, helping pharmaceutical laboratories improve accuracy, efficiency, and regulatory compliance.
Our Pharma Bites section explores the growing importance of Q3 structural characterization in pharmaceutical deformulation and reverse engineering. As the industry prepares for the upcoming patent cliff, advanced characterization techniques are becoming increasingly critical for developing complex generic and specialty formulations.
April was also marked by key organizational milestones. The ImageProVision Annual Review Meeting 2026 brought together teams from across India to review achievements, align strategic priorities, and define the roadmap for the year ahead. This was followed by IPV Ascension 2026, our annual celebration recognizing employee achievements, leadership, and contributions that drive our continued success.
To strengthen employee development, ImageProVision launched a dedicated Learning & Development (L&D) Department and successfully conducted its first comprehensive technical training program for Service Engineers, reinforcing our commitment to continuous learning and professional growth.
The month concluded with year-end celebrations, employee birthdays, and team-building activities that reflected the collaborative culture and strong sense of community that define ImageProVision.
With 556 installations worldwide, ImageProVision continues to advance AI-powered analytical solutions while investing in people, innovation, and customer success.
To access full newsletter Click Here
